Mr Ziegert, is a doctor, graduate of the Medical University in Gdansk. He is the President of the Management Board and CEO of Bioton SA. He has been connected with the pharmaceutical industry for over sixteen years, working in Poland and abroad for such concerns as Eli Lilly, Egis Group (a part of Servier group) and Ipsen. He has business experience covering different sectors of the pharmaceutical industry, including biotechnology and in particular business development within the scope of endocrinology and treatment of diabetes.

From 1993 to 2004, Mr. Slawomir Ziegert worked in the Polish branch of Eli Lilly, one of the world’s leading pharmaceutical concerns and manufacturers of recombinant human insulin and insulin analogues, where he was responsible for the development of diabetes business, relations with the diabetes environment and government affairs. From 1998 to 2000, he was also Eli Lilly’s Country Manager in Slovakia, supervising among others, the development of sale of insulins and antibiotics. He served also as the CEO of Egis Pharmaceuticals (a part of Servier group) with responsibility for the Baltic States area and as CEO of Ipsen Poland.